⚠ Disclaimer: This report is generated using AI tools and is for informational purposes only. It does not constitute investment advice. Please consult a registered financial advisor before making any investment decisions.
ASTERDM - Technical Analysis with Chart Patterns & Indicators
Back to ListTechnical Rating: 3.6
| Stock Code | ASTERDM | Market Cap | 28,857 Cr. | Current Price | 557 ₹ | High / Low | 732 ₹ |
| Stock P/E | 87.5 | Book Value | 85.6 ₹ | Dividend Yield | 0.94 % | ROCE | 139 % |
| ROE | 200 % | Face Value | 10.0 ₹ | DMA 50 | 605 ₹ | DMA 200 | 595 ₹ |
| Chg in FII Hold | -0.26 % | Chg in DII Hold | -0.20 % | PAT Qtr | 58.9 Cr. | PAT Prev Qtr | 105 Cr. |
| RSI | 44.0 | MACD | -18.0 | Volume | 4,49,049 | Avg Vol 1Wk | 5,64,118 |
| Low price | 386 ₹ | High price | 732 ₹ | PEG Ratio | 0.29 | Debt to equity | 0.28 |
| 52w Index | 49.4 % | Qtr Profit Var | -11.7 % | EPS | 5.86 ₹ | Industry PE | 45.1 |
📈 Technical Analysis
- Chart Patterns: Price (557 ₹) is below both 50 DMA (605 ₹) and 200 DMA (595 ₹), showing weakness.
- Moving Averages: Downward bias as stock trades under short- and long-term averages.
- RSI: At 44.0, neutral momentum with slight bearish tilt.
- MACD: Negative (-18.0), bearish crossover persists.
- Bollinger Bands: Price near lower band, support seen around 550–560 ₹.
- Volume Trends: Current volume (4.49L) is below 1-week average (5.64L), showing weak participation.
🎯 Momentum & Trade Zones
- Support Levels: 550–560 ₹ (near Bollinger lower band), 386 ₹ (recent low).
- Resistance Levels: 595 ₹ (200 DMA), 605 ₹ (50 DMA), 650–670 ₹ (psychological barrier).
- Entry Zone: 550–560 ₹ (accumulation near support).
- Exit Zone: 595–605 ₹ (profit booking near resistance).
- Trend: Consolidating with bearish bias; reversal possible if price sustains above 595–605 ₹.
✅ Positive
- ROCE (139%) and ROE (200%) reflect exceptional efficiency.
- Debt-to-equity ratio at 0.28, relatively low leverage.
- Dividend yield of 0.94% provides shareholder returns.
- PEG ratio (0.29) indicates attractive valuation relative to growth.
- 52-week index return of 49.4% highlights strong long-term performance.
⚠️ Limitation
- Stock trading below both 50 DMA and 200 DMA, reflecting technical weakness.
- High P/E (87.5) compared to industry average (45.1), suggesting overvaluation.
- EPS at 5.86 ₹ is modest relative to valuation multiples.
- Volume participation is weak, reducing conviction in price moves.
📉 Company Negative News
- FII holdings decreased (-0.26%) and DII holdings decreased (-0.20%), showing reduced institutional confidence.
- Quarterly PAT declined (58.9 Cr. vs 105 Cr.), showing profit contraction.
- MACD remains negative, reflecting weak momentum.
📊 Company Positive News
- ROCE and ROE are exceptionally high, reflecting strong operational efficiency.
- PEG ratio (0.29) suggests attractive growth potential relative to valuation.
- 52-week return of 49.4% highlights investor optimism.
🏭 Industry
- Industry P/E at 45.1, much lower than company’s 87.5, suggesting sector peers may be more attractively priced.
- Healthcare and hospital sector demand remains resilient, driven by rising medical needs and expansion in India and GCC markets.
📝 Conclusion
- ASTERDM is consolidating with bearish bias, trading below key moving averages.
- Optimal entry near 550–560 ₹ with exit around 595–605 ₹.
- Strong ROCE, ROE, and PEG ratio make it attractive, but high valuation and declining profits limit upside.
- Medium-term investors should wait for breakout above 595–605 ₹ to confirm reversal trend.